RESP-VIR

Italy
|
2025-2026
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Non-hospital health centre
  • SARS-CoV-2
  • Respiratory syncytial virus
  • Influenza virus
  • Adenovirus
  • Metapneumovirus
  • Parainfluenza Virus
  • Rhinovirus
  • Respiratory syncytial virus infection
  • Influenza
  • COVID-19
  • Adenovirus infection
  • Metapneumovirus infection
  • Parainfluenza virus infection
  • Rhinovirus infection

Herder

Sweden
|
2018-2023
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Chlamydia
  • Gonorrhea

Weidlich

Germany
|
2021-2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Men who have sex with men
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Sexually transmitted infection
  • Non pharmacological intervention
  • RT-PCR

DanPrEPD

Denmark
|
2022-2022
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Primary care
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • Sexually transmitted infection
  • Syphilis
  • Pharmacological intervention
  • Antivirals
  • PrEP-HIV

SeVIHPrEP

Spain
|
2020-2030
  • Adults (18-64 years)
  • Elderly (≥65 years)
  • People at high risk of STIs
  • Men who have sex with men
  • PrEP users
  • Non-hospital health centre
  • STD/STI clinic
  • Chlamydia trachomatis
  • Neisseria gonorrhoeae
  • Treponema pallidum
  • HIV
  • Mycoplasma genitalium
  • Hepatitis
  • Sexually transmitted infection
  • Anal-rectal swab
  • Oral swab
  • Urethral exudate
  • Pharmacological intervention
  • PrEP-HIV

EuCARE-POSTCOVID

Italy Poland Portugal Lithuania Brazil Mexico Germany
|
2022
  • Adults (18-64 years)
  • Hospital
  • Primary care
  • Non-hospital health centre
  • Emergency department
  • Long-term care facility
  • SARS-CoV-2
  • Post-COVID-19
  • Blood sample
  • Nasopharyngeal swab

Zurich Coronavirus Cohort

Switzerland
|
2020
  • Adults (18-64 years)
  • General population
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Post-COVID-19

Tibble

United Kingdom
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Infants (<1 year)
  • Adolescents (12-17 years)
  • Children (1-11 years)
  • Hospital
  • Outpatient clinic
  • Community
  • Non-hospital health centre
  • SARS-CoV-2
  • Acute COVID-19

Sanz-Munoz

Spain
|
2021-2022
  • Adults (18-64 years)
  • General population
  • Elderly (≥65 years)
  • Community
  • Non-hospital health centre
  • Long-term care facility
  • Influenza virus
  • Influenza A(H5N1) virus
  • Influenza A(H7N9) virus
  • Avian Influenza
  • Pharmacological intervention
  • Vaccination

MoVIHvax

Spain
|
2022
  • Adults (18-64 years)
  • People at high risk of STIs
  • Outpatient clinic
  • Non-hospital health centre
  • STD/STI clinic
  • Monkeypox virus
  • Mpox
  • Blood sample

PISCIS

Spain
|
2022-2022
  • Adults (18-64 years)
  • Fragile population
  • People at high risk of STIs
  • Immunocompromised host
  • PrEP users
  • People living with HIV
  • Non-hospital health centre
  • Telemedicine
  • Monkeypox virus
  • Mpox
  • Pharmacological intervention
  • Vaccination